mRNA Vaccines & Therapeutics 2017: An Industry Analysis of Technologies, Pipelines, Stakeholders and Deals - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "mRNA Vaccines & Therapeutics 2017: an Industry Analysis of Technologies, Pipelines, Stakeholders and Deals" report to their offering.

"mRNA Vaccines & Therapeutics 2017: an industry analysis of technologies, pipelines, stakeholders and deals" as of June 2017 brings you up-to-date regarding key mRNA players, key mRNA technologies and applications, mRNA vaccines & therapeutics, business projects, business deals and funding opportunities.

The report analyzes the mRNA vaccine and therapeutic pipelines and stakeholders in the field, especially technology companies and rare disease biopharma and major pharmaceutical companies. The report highlights the value of mRNA vaccines and therapeutics in terms of partnering economic condition and equity financing rounds.

mRNA Technologies have attracted more than US$ 3.4 billion in equity financing and frontloaded partnership payments. Further billions of US$ have been committed to mRNA R&D funding and potential milestone payments. A select group of major pharmaceutical and rare disease specialist biopharmaceutical companies have partnered with mRNA technology companies. At least 16 mRNA vaccines and therapeutics are in clinical stages and a considerable number is in IND or pre-IND stage.

Key Topics Covered:

1 Executive Summary

2 Introduction & Overview

3 Profiles of mRNA-based Vaccines & Therapeutics

  • Standardized Therapeutic Cancer mRNA Vaccines
  • Individualized Therapeutic Cancer mRNA Vaccines
  • Therapeutic Infectious Disease mRNA Vaccines
  • Prophylactic Infectious Disease mRNA Vaccines & Adjuvants
  • mRNA in Immuno-Oncology
  • mRNA Therapeutic for Monogenetic Diseases
  • mRNA Therapeutic for Other Diseases

4 Pipeline Analysis

  • Standardized mRNA Cancer Vaccines
  • Individualized mRNA Cancer Vaccines
  • Therapeutic mRNA Infectious Disease Vaccines
  • Prophylactic mRNA Infectious Disease Vaccines
  • Replicon RNA Infectious Disease Vaccines
  • mRNA Protein Therapeutics for Cancer and Cardiovascular Diseases
  • mRNA Protein Therapeutics for Ornithine TransCarbomylase (OTC) Deficiency
  • mRNA Protein Therapeutics for Cystic Fibrosis
  • mRNA Protein Therapeutics for Other Genetic Diseases
  • mRNA Antibody Therapeutics
  • Therapeutic mRNA-based Gene Editing
  • Ex vivo mRNA-based T-Cell Engineering

5 Profiles of Selected mRNA & Delivery Technologies

  • Ex vivo mRNA Loading
  • In vivo Carrier & mRNA
  • mRNA Vaccines & Stimulants / Adjuvants

6 Technology Analysis

  • mRNA Modifications
  • mRNA Efficiencies
  • Adjuvant/Stimulant & Carrier Technologies for mRNA-based Vaccines
  • Carriers for mRNA-based Protein & Antibody Therapeutics

7 Company Profiles

  • Companies focused on mRNA Therapeutics and Vaccines
  • Companies with a focus on self-amplifying mRNA (Replicon RNA)
  • Companies with a focus on mRNA Delivery
  • Companies with a focus on Gene Editing and CAR T-Cells
  • Companies focused on Contract Manufacturing of mRNA
  • Biopharmaceutical Companies with mRNA Programs
  • Major Pharmaceutical Companies with mRNA Programs

8 Stakeholder Analysis

  • mRNA Technology Companies
  • Pharmaceutical Companies with mRNA Programs

9 mRNA Manufacturing

  • In-house mRNA Manufacturing
  • Out-sourced mRNA Manufacturing

10 Financial Perspective on mRNA

  • mRNA Partnering Deals
  • Funded mRNA Programs

11 Outlook

12 References

Companies Mentioned

  • Acuitas Therapeutics
  • Alexion Pharmaceuticals
  • Arbutus Biopharma
  • Arcturus Therapeutics
  • Argos Therapeutics
  • AstraZeneca
  • Bayer
  • BioNTech
  • Boehringer Ingelheim
  • CRISPR Therapeutics
  • CureVac
  • eTheRNA immunotherapies
  • Ethris
  • GlaxoSmithKline Vaccines
  • In-Cell-Art
  • Intellia Therapeutics
  • Kernal Biologics
  • MaxCyte
  • Moderna Therapeutics
  • Novartis
  • PhaseRx
  • Precision NanoSystems
  • RaNa Therapeutics
  • Regeneron Pharmaceuticals
  • Roche
  • Sangamo Therapeutics
  • Sanofi
  • Siemens
  • Silence Therapeutics
  • Synthetic Genomics
  • Takeda Pharmaceutical Co
  • Tiba Biotechnology
  • TriLink BioTechnologies
  • Ultragenyx Pharmaceutical
  • Vertex Pharmaceuticals

For more information about this report visit https://www.researchandmarkets.com/research/qlp66r/mrna_vaccines_and

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Vaccines

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Vaccines